Short-term memory and cerebral ischemia: pharmacological application.
Transient ischemia results in changes in the cerebral blood flow at the level of microinfarcts, enzymatic and metabolic changes and the development of a cerebral edema; all these disorders regress in the week following ischemia. Besides, the observed functional disorders disappear as the cerebral edema regresses. The brain functional activity is protected by the use of treatments which reduce the development of the cerebral edema and/or a quicker regression of the edema.
D000818:Animals; D001362:Avoidance Learning; D001929:Brain Edema / Q000378:metabolism; D002560:Cerebrovascular Circulation; D003847:Deoxyglucose; D004924:Escape Reaction; D002546:Ischemic Attack, Transient / Q000503:physiopathology*; D008570:Memory, Short-Term; D009257:Nafronyl / Q000494:pharmacology; D009530:Nicergoline / Q000494:pharmacology; D010936:Plant Extracts / Q000494:pharmacology; D051381:Rats; D013806:Theophylline / Q000031:analogs & derivatives / Q000494:pharmacology
D010936:Plant Extracts; D009257:Nafronyl; D003847:Deoxyglucose; D013806:Theophylline; D009530:Nicergoline; C031576:lomifylline